Product Information

LAMICTAL 100 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $10.9173 per EA under NDC 00173064255. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 27, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMICTAL 100 MG TABLET

lamotrigine
$10.9173per EA
High Outlier

Strength

100 mg/1

NDC

00173064255

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA020241

FDA Approved

12/27/1994

TE Code

AB

On Market Since

1/17/1995

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMICTAL 100 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 54.7%. The table below summarizes its recorded NADAC range and movement.

Current price$10.9173 per EA
All-time high$17.4529 (Oct 11, 2023)
All-time low$7.0566 (Nov 28, 2013)
52-week high$10.9454
52-week low$10.9123
Median price$12.6999
Average price$12.6594
Largest weekly change-39.0% (Dec 27, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.3%

3Y

-37.4%

5Y

-27.7%

All

+54.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMICTAL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 100 MG TABLET, manufactured by GlaxoSmithKline LLC, is $10.9173 per EA (NDC 00173064255), effective Aug 19, 2026.

How has the price of LAMICTAL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMICTAL 100 MG TABLET has risen 54.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMICTAL 100 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMICTAL 100 MG TABLET has ranged from a low of $7.0566 (Nov 28, 2013) to a high of $17.4529 (Oct 11, 2023), with a median of $12.6999 per EA.

Are there cheaper alternatives to LAMICTAL 100 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LAMICTAL 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LAMICTAL 100 MG TABLET?

LAMICTAL 100 MG TABLET (NDC 00173064255) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.